Table of Contents
| << Previous Issue | Nov 2025 (Vol: 2025, Issue: 11) |
- Section: Licensing
-
Gilead’s Kite Signs US$1.64 B In Vivo CAR-T Deal with Pregene Biopharma
- Section: Mergers & Acquisitions
-
Novartis to Acquire Neuromuscular Specialist Avidity Biosciences for US$12 B
- Section: Research & Development
-
ModeX Therapeutics and Regeneron Collaborate to Develop Multispecific Antibodies for USS$1 B




RSS